Sunitinib-induced hand-foot syndrome: A new, distinct form

Clinical and Experimental Dermatology

Volumn 35, Issue 2, 2010, Pages 200-201

  Fife, D J ^a   Wu, J J ^b   Behnam, S E ^c   Linden, K G ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; SUNITINIB; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; PYRROLE DERIVATIVE;

AGED; CANCER RADIOTHERAPY; CASE REPORT; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ERYTHEMA; FINGER; FOOT SOLE; GASTROINTESTINAL STROMAL TUMOR; HAND FOOT SYNDROME; HAND PALM; HUMAN; LETTER; MALE; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN DEFECT; SKIN EXAMINATION; SKIN INDURATION; SKIN PAIN; VIET NAM; CHEMICALLY INDUCED; DRUG ERUPTIONS; HAND DISEASE; SKIN DISEASE; SYNDROME;

AGED; ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; INDOLES; MALE; PYRROLES; SYNDROME;

EID: 75849141488     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03318.x     Document Type: Letter

References (5)

1. Tsai KY, Yang CH, Kuo TT et al. Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma. J Clin Oncol 2006 24: 5786 5788.
2. Porta C, Paglino C, Imarisio I, Bonomi L. Uncovering Pandora's vase; the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib. Clin Exp Med 2007 7: 127 134.
3. Rosenbaum SE, Wu S, Newman MA et al. Dermatologic reactions to the multitargeted tyrosine kinase inhibitor sunitinib. Support Care Cancer 2008 16: 557 566.
4. Demircay Z, Gurbuz O, Alpdogan TB et al. Chemotherapy-induced acral erythema in leukemic patients. A report of 15 cases. Int J Dermatol 1997 36: 593 598.
5. Janusch M, Fischer M, Marsch WC et al. The hand-foot syndrome-a frequent secondary manifestation in antineoplastic chemotherapy. Eur J Dermatol 2006 16: 494 499.